NTBL vs OGEN

Comparison between Notable Labs Inc Ord (NTBL, Company) and Oragenics Inc (OGEN, Company).

Both NTBL and OGEN are from the Healthcare sector.

NTBL vs OGEN - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	NTBL(COMPANY)	OGEN(COMPANY)
Market Cap	$2.39M	$2.40M
Max Drawdown	94.56%	100.00%
Sharpe Ratio	-1.02	-1.37
5Y Beta	0.33	0.00
Industry	Biotechnology	Biotechnology
P/E Ratio	N/A	-0.25
PEG Ratio	N/A	0.00
Debt to Equity	N/A	0.00%
P/S Ratio	7.65	89.28
P/B Ratio	0.03	0.40

Market Cap

NTBL

$2.39M

Winner

OGEN

$2.40M

Max Drawdown

Winner

NTBL

94.56%

OGEN

100.00%

Sharpe Ratio

Winner

NTBL

-1.02

OGEN

-1.37

5Y Beta

NTBL

0.33

Winner

OGEN

0.00

Industry

NTBL

Biotechnology

OGEN

Biotechnology

P/E Ratio

NTBL

N/A

OGEN

-0.25

PEG Ratio

NTBL

N/A

OGEN

0.00

Debt to Equity

NTBL

N/A

OGEN

0.00%

P/S Ratio

Winner

NTBL

7.65

OGEN

89.28

P/B Ratio

Winner

NTBL

0.03

OGEN

0.40

NTBL vs OGEN - Historical Returns

Returns include dividend reinvestment.

Period	NTBL	OGEN
1 month	+0.00%	-1.76%
3 months	+0.00%	-9.77%
6 months	N/A	-29.77%
1 year	N/A	-83.75%
5 years(CAGR)	N/A	-78.59%
10 years(CAGR)	N/A	-62.42%
Max(CAGR)	-65.87%	-48.40%

Winner

NTBL

+0.00%

OGEN

-1.76%

Winner

NTBL

+0.00%

OGEN

-9.77%

NTBL

N/A

OGEN

-29.77%

NTBL

N/A

OGEN

-83.75%

5Y(CAGR)

NTBL

N/A

OGEN

-78.59%

10Y(CAGR)

NTBL

N/A

OGEN

-62.42%

Max(CAGR)

NTBL

-65.87%

Winner

OGEN

-48.40%

NTBL vs OGEN - Annual Returns (2004 - 2026)

Returns include dividend reinvestment.

Year	NTBL	OGEN
2026	+0.00%	-29.76%
2025	N/A	-92.75%
2024	-86.53%	-94.55%
2023	-57.53%	-19.58%
2022	N/A	-77.77%
2021	N/A	-14.21%
2020	N/A	-11.96%
2019	N/A	-40.25%
2018	N/A	-62.00%
2017	N/A	-54.90%
2016	N/A	-60.58%
2015	N/A	+74.42%
2014	N/A	-68.93%
2013	N/A	+4.07%
2012	N/A	+140.00%
2011	N/A	-66.33%
2010	N/A	-53.13%
2009	N/A	+15.38%
2008	N/A	-43.18%
2007	N/A	-63.06%
2006	N/A	+168.29%
2005	N/A	-89.25%
2004	N/A	-9.41%